Search

Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.

Read about a powerful research model developed by MSK researchers to learn how the most common type of prostate cancer changes into a deadly form.

MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.

During the June 8 edition of “MSK Science Spotlight,” radiochemist Jason Lewis, PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.”

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Learn more about Memorial Sloan Kettering’s newsletter for cancer survivors, which is celebrating its tenth year of publication.

Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.